Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
3 Who Should Take Weight Loss Injections, and Who Shouldnt
NOTE: The GLP-1 drug class is FDA-approved in ages 12+
Thats the difference between stalled progress and staying locked in with your nutrition, performance, and overall health and wellness strategy
16 A sub-study of the SURPASS-3 trial on overweight/obese patients with T2DM demonstrated that tirzepatide decreased liver fat by 8.1% over 52 weeks, along with significant reductions in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (NCT03882970), 17 indicating that tirzepatide may improve liver steatosis or inflammation
This insight may help provide context about your metabolic predisposition and can support a more personalized conversation with a provider about whether medication-supported management is appropriate for you
Understanding your genetic background in these peptide pathways supports a more informed conversation with your provider about whether standard weekly tirzepatide, oral formulations, or other GLP-1based protocols may align best with your metabolic profile and lifestyle
